Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses

Nature Protocols

Volumn 5, Issue 6, 2010, Pages 1033-1041

  Sáez Cirión, Asier ^a   Shin, So Youn ^a,b   Versmisse, Pierre ^a   Barré Sinoussi, Françoise ^a   Pancino, Gianfranco ^a  

^a INSTITUT PASTEUR   (France)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; P24 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

AIDS VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; VIRUS REPLICATION;

EID: 77956672262     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2010.73     Document Type: Article

References (29)

1. Borrow, P., Lewicki, H., Hahn, B.H., Shaw, G.M., Oldstone, M.B., Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103-6110 (1994).
2. Jin, X. et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991-998 (1999).
3. Kiepiela, P. et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13, 46-53 (2007).
4. Martinez-Picado, J. et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80, 3617-3623 (2006).
5. Mackewicz, C.E., Ortega, H.W., Levy, J.A., CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Investig. 87, 1462-1466 (1991).
6. Tsubota, H., Lord, C.I., Watkins, D.I., Morimoto, C., Letvin, N.L., A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. Exp. Med. 169, 1421-1434 (1989).
7. Yang, O.O. et al. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71, 3120-3128 (1997).
8. Walker, B.D., Burton, D.R., Toward an AIDS vaccine. Science 320, 760-764 (2008).
9. Appay, V., Douek, D.C., Price, D.A., CD8+ T cell efficacy in vaccination and disease. Nat. Med. 14, 623-628 (2008).
10. D’Souza, M.P., Altfeld, M., Measuring HIV-1-specific T cell immunity: how valid are current assays? J. Infect. Dis. 197, 337-339 (2008).
11. Deeks, S.G., Walker, B.D. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of ant, iretroviral therapy. Immunity 27, 406-416 (2007).
12. O’Connell, K.A., Bailey, J.R., Blankson, J.N., Elucidating the elite: mechanisms of control in HIV-1 infection. Trends Pharmacol. Sci. 30, 631-637 (2009).
13. Saez-Cirion, A., Pancino, G., Sinet, M., Venet, A., Lambotte, O., HIV controllers: how do they tame the virus? Trends Immunol. 28, 532-540 (2007).
14. Gea-Banacloche, J.C. et al. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J. Immunol. 165, 1082-1092 (2000).
15. Saez-Cirion, A. et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J. Immunol. 182, 7828-7837 (2009).
16. Baker, B.M., Block, B.L., Rothchild, A.C., Walker, B.D., Elite control of HIV infection: implications for vaccine design. Expert Opin. Biol. Ther. 9, 55-69 (2009).
17. Betts, M.R. et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107, 4781-4789 (2006).
18. Migueles, S.A. et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3, 1061-1068 (2002).
19. Migueles, S.A. et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29, 1009-1021 (2008).
20. Sáez-Cirión, A. et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivoand peculiar CTL activation phenotype. Proc. Natl Acad. Sci. USA 104, 6776-6781 (2007).
21. Migueles, S.A. et al. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J. Virol. 83, 11876-11889 (2009).
22. Vojnov, L. et al. Effective simian immunodeficiency virus-specific CD8+ T cells lack an easily detectable, shared characteristic. J. Virol. 84, 753-764 (2010).
23. Sacha, J.B. et al. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J. Immunol. 178, 2746-2754 (2007).
24. Almeida, J.R. et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 113, 6351-6360 (2009).
25. Streeck, H., Frahm, N., Walker, B.D., The role of IFN-gamma Elispot assay in HIV vaccine research. Nat. Protoc. 4, 461-469 (2009).
26. van t Wout, A.B., Schuitemaker, H., Kootstra, N.A., Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. Nat. Protoc.3, 363-370 (2008).
27. Perfetto, S.P., Ambrozak, D., Nguyen, R., Chattopadhyay, P., Roederer, M., Quality assurance for polychromatic flow cytometry. Nat. Protoc. 1, 1522-1530 (2006).
28. O’Doherty, U., Swiggard, W.J., Malim, M.H., Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74, 10074-10080 (2000).
29. Lamoreaux, L., Roederer, M., Koup, R., Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 1, 1507-1516 (2006).